Company: UMBFO
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028420
Chunk: 209

Company: UMB FINANCIAL CORP
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1B
Chunk 209
---
 issued upon exercise of outstanding options, warrants and rights (a)

    Weighted average exercise price of outstanding options, warrants and rights(b)

    Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))(c)

    Equity compensation plans approved by security holders

    2005 Long Term Incentive Plan

    30,214

    $
    63.87

    None

    2018 Omnibus Incentive Compensation Plan
     
    None

    None

    2,654,281

    Equity compensation plans not approved by security holders
     
    None

    None

    None

    Total

    30,214

    $
    63.87

    2,654,281

For additional information concerning the Company’s equity compensation plans, see Note 11, “Employee Benefits,” in the Notes to the Consolidated Financial Statements provided in Item 8 of this report.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by this item is incorporated herein by reference to the information to be provided under the captions “Corporate Governance – Transactions with Related Persons”, “Corporate Governance – The Board of Directors – Independent Directors” and “Corporate Governance – Committees of the Board of Directors” of the Company's Proxy Statement for the 2025 Annual Meeting of Shareholders, which will be provided to shareholders within 120 days after December 31, 2024.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by this item is incorporated herein by reference to the information to be provided under the caption "Proposal #3: Ratification of the Corporate Audit Committee’s Engagement of KPMG LLP as UMB’s Independent Public Accounting Firm for 2025” of the Company's Proxy Statement for the 2025 Annual Meeting of Shareholders, which will be provided to shareholders within 120 days after December 31, 2024.

144

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

Consolidated Financial Statements and Financial Statement Schedules

The following Consolidated Financial Statements of the Company are included in Item 8 of this Annual Report on Form 10-K.

Consolidated Balance Sheets as of December 31, 2024 and 2023

Consolidated Statements of Income for the Three Years Ended December 31, 2024